Pharmaceutical Excipients Market Analysis, Growth Forecast Analysis by Manufacturers, Regions, Type by 2023

The global pharmaceutical excipients market is growing, due to the high growth of pharmaceutical industry, increasing demand of excipients in generics market due to the patent cliffs, emergence of new excipients, increasing prevalence of chronic diseases, and aging population.
The increasing focus of drug manufacturers in the emerging economies of Asia-Pacific and Latin America, such as India, China and Brazil, and the development of multi-functionality excipients are creating ample revenue generation opportunities for the major pharmaceutical excipients manufacturers.
Pharmaceutical excipients are natural or synthetic inactive substances used alongside the active pharmaceutical ingredient of a drug. These substances perform their functions without altering or modifying the therapeutic action of the active pharmaceutical ingredient.

Geographically, North America held the largest share in the global market in 2015, owing to the high healthcare expenditure, presence of a large number of manufacturers, increasing prevalence of chronic diseases and technological advances in pharmaceutical industries.
Read summary of report here : https://www.psmarketresearch.com/market-analysis/pharmaceutical-excipients-market
Some of the key players operating in the global pharmaceutical excipients market include Archer Daniels Midland Company, Ashland, BASF SE, Associated British Foods plc, The Dow Chemical Company, Croda International Plc, FMC Corporation, Evonik Industries AG, The Lubrizol Corporation and ROQUETTE.
Comments
Post a Comment